Therefore, Investors and venture capitalists are looking for the next best thing, but with a quick return on investment.
Finding investors for this industry can be difficult because investors see the FDA and the DEA is a major obstacle; especially in medical cannabis industry. These start-up companies are usually not equipped to handle such large regulatory institutions.